Panel discussion: Immunogenicity assessment of therapeutic proteins

56:37

Webinar: Singlicate ADA analysis

36:23

Webinar: Unlocking precision medicine: An overview of Illumina’s TSO 500

57:36

Best practices for the validation of hybrid LC-MS/MS assays

55:01

Panel Session: Bioanalysis zone

55:42

Best practices for laboratory solutions relating to Cell and Gene Therapy clinical trials

1:01:13

Webinar: Digital solutions to alleviate NASH clinical trial challenges

52:54

Biomarker assays - bioanalytical meets CLIA

46:53

Multi-diagnostic approaches for patient selection biomarkers in immuno-oncology

28:23

NASH Clinical Trials: Challenges and Considerations

Dr. Andrew Roche discusses overcoming the challenges and considerations associated with NASH Clinical Trials and examination of potential strategies to address during trial design or study execution.

46:50

Laboratory Considerations When Developing Multiple Myeloma Trials

Join ICON’s experts Dr. Marc Golightly, PhD and Domenica Gandini as they speak about considerations when developing Multiple Myeloma trials. With the growing number of therapeutics being developed for Multiple Myeloma, the need for laboratory expert

58:49

Addressing the challenges of Type II Diabetes global clinical trials via high quality lab solutions

Join ICON’s expert Dr. Andrew Roche, PhD as he speaks about overcoming challenges when developing Diabetes trials. Addressing these challenges via use of high quality tools is critical to successful completion of a clinical trial.

59:34